TECXTectonic Therapeutic, Inc.

$634M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$190,000

Operating Income

-$18M

Net Income

-$17M

EPS (Diluted)

$-8.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$117M

Total Liabilities

$11M

Stockholders' Equity

$107M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$190,000	-$21,000	-804.8%
Operating Income	-$18M	-$8M	-127.3%
Net Income	-$17M	-$8M	-107.5%

TECX Q1 2019 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena